text
"['\nX. 대주주 등과의 거래내용\n1. 대주주 등에 대한 신용공여 등가. 채무보증내역\n(단위: 천원)\n제공받는자\n당기말\n전기말\n보증기간\n지급보증액\n지급보증처\n지급보증액\n지급보증처\n아이디언스㈜\n1,140,000\n우리은행\n1,200,000\n우리은행\n2022-11-11~2023-03-24\n6,840,000\n우리은행\n7,200,000\n우리은행\n2022-11-11~2023-03-24\n일동생활건강㈜\n-\n한국씨티은행(*1)\n3,000,000\n한국씨티은행(*1)\n2021-07-29~2022-01-28\n1,200,000\n우리은행\n-\n-\n2022-02-03~2023-02-03\n4,200,000\n신한은행\n4,200,000\n신한은행\n2022-05-26~2023-05-26\n1,800,000\n우리은행\n1,800,000\n우리은행\n2022-05-29~2023-05-28\n일동히알테크㈜\n1,200,000\n우리은행\n1,200,000\n우리은행\n2022-07-27~2023-07-27\n1,200,000\n신한은행\n1,200,000\n신한은행\n2022-07-27~2023-07-27\n1,200,000\n신한은행\n1,200,000\n신한은행\n2022-10-23~2023-04-23\n1,200,000\n신한은행\n1,200,000\n신한은행\n2022-02-18~2023-02-18\n1,200,000\n신한은행\n1,200,000\n신한은행\n2022-04-30~2023-04-29\n1,200,000\nNH농협\n1,200,000\nNH농협\n2022-07-03~2023-07-02\n9,000,000\nKEB하나은행(*2)\n10,200,000\nKEB하나은행(*2)\n2022-07-27~2023-07-27\n1,200,000\n우리은행\n-\n-\n2022-07-27~2023-07-27\n-\n신한금융투자\n7,200,000\n신한금융투자\n2021-10-08~2022-10-07\n3,600,000\nKEB하나은행\n3,600,000\nKEB하나은행\n2022-12-16~2023-12-15\n일동바이오사이언스㈜\n285,000\nKEB하나은행\n1,425,000\nKEB하나은행\n2019-03-18~2023-03-17\n5,400,000\nKEB하나은행\n5,400,000\nKEB하나은행\n2022-07-27~2023-07-27\n1,200,000\nNH농협\n-\n0\n2022-10-11~2023-10-11\n1,200,000\n신한은행\n1,200,000\n신한은행\n2022-07-29~2023-07-29\n6,000,000\n한국씨티은행(*3)\n7,200,000\n한국씨티은행(*3)\n2022-07-28~2023-01-29\n7,200,000\n한국씨티은행(*3)\n7,200,000\n한국씨티은행(*3)\n2022-07-28~2023-01-29\n후다닥㈜\n1,200,000\nNH농협\n-\n-\n2022-02-25~2023-02-25\n합 계\n57,465,000\n\u3000\n68,025,000\n\u3000\n\u3000\n(*1) 일동홀딩스㈜, 일동제약㈜, 일동바이오사이언스㈜, 일동히알테크㈜가 연대하여 보증하고 있습니다.(*2) 일동홀딩스㈜, 일동제약㈜, 일동바이오사이언스㈜가 연대하여 보증하고 있습니다.(*3) 일동홀딩스㈜, 일동제약㈜, 일동히알테크㈜가 연대하여 보증하고 있습니다.\n']"
